C4 Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2020 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: C4 Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q3 2022.
C4 Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2022 was $264M, a 10.4% increase year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$264M	+$24.8M	+10.4%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$250M	+$65.7M	+35.6%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$245M	+$26.6M	+12.2%	Mar 31, 2022	10-Q	2022-05-05
Q4 2021	$233M	+$43.2M	+22.7%	Dec 31, 2021	10-Q	2022-11-03
Q3 2021	$239M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$185M			Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$219M			Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$190M			Dec 31, 2020	10-K	2022-02-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.